Whole Exon Deletion in the GFAP Gene Is a Novel Molecular Mechanism Causing Alexander Disease.

Published on Dec 18, 2017in Neuropediatrics1.549
· DOI :10.1055/S-0037-1608921
Lydia Green3
Estimated H-index: 3
(Leeds Teaching Hospitals NHS Trust),
Ian R. Berry9
Estimated H-index: 9
(St James's University Hospital)
+ 9 AuthorsJohn H. Livingston31
Estimated H-index: 31
(Leeds Teaching Hospitals NHS Trust)
Sources
Abstract
Alexander disease (AD) is a leukodystrophy caused by heterozygous mutations in the gene encoding the glial fibrillary acidic protein (GFAP). Currently, de novo heterozygous missense mutations in the GFAP gene are identified in over 95% of patients with AD. However, patients with biopsy-proven AD have been reported in whom no GFAP mutation has been identified. We report identical twin boys presenting in infancy with seizures and developmental delay in whom MR appearances were suggestive of AD with the exception of an unusual, bilateral, arc of calcification at the frontal white–gray junction. Initial mutation screening of the GFAP gene did not identify a mutation. Whole exome sequencing in both brothers revealed a de novo heterozygous in-frame deletion of the whole of exon 5 of the GFAP gene. Mutations in the GFAP gene are thought to result in a toxic effect of mutant GFAP disrupting the formation of the normal intermediate filament network and resulting in Rosenthal fiber formation, which has hitherto not been linked to exonic scale copy number variants in GFAP. Further studies on mutation negative AD patients are warranted to determine whether a similar mechanism underlies their disease.
📖 Papers frequently viewed together
10 Authors (Mu-Hui Fu, ..., Min-Yu Lan)
1 Citations
10 Citations
2 Citations
References14
Newest
#1Christopher M. Watson (St James's University Hospital)H-Index: 17
#2Laura A. Crinnion (St James's University Hospital)H-Index: 10
Last. David T. Bonthron (St James's University Hospital)H-Index: 61
view all 10 authors...
Background The widespread adoption of high-throughput sequencing technologies by genetic diagnostic laboratories has enabled significant expansion of their testing portfolios. Rare autosomal recessive conditions have been a particular focus of many new services. Here we report a cohort of 26 patients referred for genetic analysis of Joubert (JBTS) and Meckel-Gruber (MKS) syndromes, two clinically and genetically heterogeneous neurodevelopmental conditions that define a phenotypic spectrum, with ...
52 CitationsSource
#1Marie-Céleste Ferreira (French Institute of Health and Medical Research)H-Index: 2
#2Imen Dorboz (Paris Diderot University)H-Index: 14
Last. Odile Boespflug Tanguy (Paris Diderot University)H-Index: 2
view all 4 authors...
Abstract Alexander disease (AxD), a fatal degenerative leukoencephalopathy, is caused by de novo heterozygous missense mutations in the Glial Fibrillary Acidic Protein (GFAP) gene. The pathological hallmark of the disease is the presence of Rosenthal fibers, cytoplasmic inclusions in astrocytes, composed mainly of GFAP, αB-crystallin and HSP27. To date, several patients with a typical presentation of the disease or displaying characteristic Rosenthal fibers in brain material have been reported w...
5 CitationsSource
#1Daniel Flint (UAB: University of Alabama at Birmingham)H-Index: 5
#2Rong Li (UAB: University of Alabama at Birmingham)H-Index: 11
Last. Michael Brenner (UAB: University of Alabama at Birmingham)H-Index: 51
view all 13 authors...
Alexander disease (AxD) is a usually fatal astrogliopathy primarily caused by mutations in the gene encoding GFAP, an intermediate filament protein expressed in astrocytes. We describe three patients with unique characteristics, and whose mutations have implications for AxD diagnosis and studies of intermediate filaments. Patient 1 is the first reported case with a non-coding mutation. The patient has a splice site change producing an in-frame deletion of exon 4 in about 10% of the transcripts. ...
22 CitationsSource
#1Morgan Prust (Children's National Medical Center)H-Index: 9
#2Jichuan Wang (Children's National Medical Center)H-Index: 34
Last. Adeline Vanderver (Children's National Medical Center)H-Index: 41
view all 34 authors...
Objective: To characterize Alexander disease (AxD) phenotypes and determine correlations with age at onset (AAO) and genetic mutation. AxD is an astrogliopathy usually characterized on MRI by leukodystrophy and caused by glial fibrillary acidic protein ( GFAP ) mutations. Methods: We present 30 new cases of AxD and reviewed 185 previously reported cases. We conducted Wilcoxon rank sum tests to identify variables scaling with AAO, survival analysis to identify predictors of mortality, and χ 2 tes...
123 CitationsSource
#1Rosalind J Jefferson (Royal Berkshire Hospital)H-Index: 6
#2Michael Absoud (Royal Berkshire Hospital)H-Index: 20
Last. Sandeep Jayawant (Boston Children's Hospital)H-Index: 28
view all 6 authors...
Alexander disease is a rare neurodegenerative leucoencephalopathy caused by de novo mutations in the GFAP gene. Infantile, juvenile, and adult subtypes have been described and the clinical and radiological phenotypes are broad. Here we report on a single case of juvenile-onset Alexander disease associated with a novel frameshift mutation in the GFAP gene. The 8-year-old male patient had a relatively mild clinical phenotype characterized by dystonia, intermittent episodes of raised intracranial p...
7 CitationsSource
#1Ming Der Perng (Durham University)H-Index: 12
#2Mu Su (UAB: University of Alabama at Birmingham)H-Index: 5
Last. Roy A. Quinlan (Durham University)H-Index: 61
view all 8 authors...
Here, we describe the early events in the disease pathogenesis of Alexander disease. This is a rare and usually fatal neurodegenerative disorder whose pathological hallmark is the abundance of protein aggregates in astrocytes. These aggregates, termed “Rosenthal fibers,” contain the protein chaperones αB-crystallin and HSP27 as well as glial fibrillary acidic protein (GFAP), an intermediate filament (IF) protein found almost exclusively in astrocytes. Heterozygous, missense GFAP mutations that u...
146 CitationsSource
#1M.S. van der Knaap (VUmc: VU University Medical Center)H-Index: 57
#2V. RameshH-Index: 1
Last. Gajja S. SalomonsH-Index: 9
view all 12 authors...
Background: Alexander disease is most commonly associated with macrocephaly and, on MRI, a leukoencephalopathy with frontal preponderance. The disease is caused by mutation of the GFAP gene. Clinical and MRI phenotypic variation have been increasingly recognized. Methods: The authors studied seven patients with Alexander disease, diagnosed based on mutations in the GFAP gene, who presented unusual MRI findings. The authors reviewed clinical history, MRI abnormalities, and GFAP mutations. Results...
154 CitationsSource
#1Rong Li (UAB: University of Alabama at Birmingham)H-Index: 11
#2Anne B. Johnson (Yeshiva University)H-Index: 39
Last. Michael Brenner (UAB: University of Alabama at Birmingham)H-Index: 51
view all 20 authors...
Alexander disease is a progressive, usually fatal neurological disorder defined by the widespread and abundant presence in astrocytes of protein aggregates called Rosenthal fibers. The disease most often occurs in infants younger than 2 years and has been labeled a leukodystrophy because of an accompanying severe myelin deficit in the frontal lobes. Later onset forms have also been recognized based on the presence of abundant Rosenthal fibers. In these cases, clinical signs and pathology can be ...
203 CitationsSource
#1Takashi Shiihara (YU: Yamagata University)H-Index: 20
#2Yukio Sawaishi (Akita University)H-Index: 19
Last. Kiyoshi Hayasaka (YU: Yamagata University)H-Index: 12
view all 5 authors...
Abstract We report on a family with dominantly inherited asymptomatic Alexander's disease due to a novel Glial fibrillary acidic protein (GFAP) mutation. The proband, a 16-month-old boy, presented with megalocephaly and brain magnetic resonance imaging (MRI) showing the typical findings of Alexander's disease. Molecular analysis showed that he was a heterozygote of the L331P mutation of GFAP. His mother and sister, without megalocephaly or other neurological abnormalities, were also heterozygote...
21 CitationsSource
#1Diana Rodriguez (University of Paris)H-Index: 47
#2Fernande Gauthier (French Institute of Health and Medical Research)H-Index: 1
Last. Odile Boespflug-Tanguy (French Institute of Health and Medical Research)H-Index: 46
view all 18 authors...
Heterozygous, de novo mutations in the glial fibrillary acidic protein (GFAP) gene have recently been reported in 12 patients affected by neuropathologically proved Alexander disease. We searched for GFAP mutations in a series of patients who had heterogeneous clinical symptoms but were candidates for Alexander disease on the basis of suggestive neuroimaging abnormalities. Missense, heterozygous, de novo GFAP mutations were found in exons 1 or 4 for 14 of the 15 patients analyzed, including pati...
171 CitationsSource
Cited By3
Newest
Abstract null null Objectives null Alexander disease (AxD) is a rare autosomal dominant disorder due to GFAP mutations; infantile AxD is the most common severe form which usually results in death. In this study, phenotype and genotype analysis of all reported cases with IAxD are reported as well as a de novo variant. null null null Methods null We conduct a comprehensive review on all reported Infantile AxD due to GFAP mutation. Clinical data and genetics of the reported patients were analyzed. ...
Source
#1Guy Helman (UQ: University of Queensland)H-Index: 17
#2Asako Takanohashi (Children's Hospital of Philadelphia)H-Index: 7
Last. Cas Simons (UQ: University of Queensland)H-Index: 30
view all 18 authors...
Alexander disease results from gain of function mutations in the gene encoding glial fibrillary acidic protein (GFAP). At least eight GFAP isoforms have been described, however, the predominant alpha isoform accounts for approximately 90% of GFAP protein. We describe exonic variants identified in three unrelated families with Type II Alexander disease that alter the splicing of GFAP pre-mRNA and result in upregulation of a previously uncharacterised GFAP lambda isoform (NM_001363846.1). Affected...
5 CitationsSource
#1Laura L. E. Whitehouse (University of Leeds)H-Index: 3
#2Claire E. L. Smith (University of Leeds)H-Index: 9
Last. Alan J. Mighell (University of Leeds)H-Index: 25
view all 13 authors...
Objectives: Variants in DLX3 cause tricho‐dento‐osseous syndrome (TDO, MIM #190320), a systemic condition with hair, nail and bony changes, taurodontism and amelogenesis imperfecta (AI), inherited in an autosomal dominant fashion. Different variants found within this gene are associated with different phenotypic presentations. To date, six different DLX3 variants have been reported in TDO. The aim of this paper was to explore and discuss three recently uncovered new variants in DLX3. Subjects an...
4 CitationsSource